Retinoic-Acid-Receptor Orphan Gamma Antagonist (Eternity Bioscience)

N/A

Report date: 2025/01/26 18:45:16
NME

Base Information

Drug NameRetinoic-Acid-Receptor Orphan Gamma Antagonist (Eternity Bioscience)
Drug Alias NameROR-gamma-T antagonist (Eternity Bioscience)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptor gamma inhibitors
TargetsRetinoic acid receptor gamma
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEternity Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesEternity Bioscience Inc
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A